戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  vaccine-induced immune responses against F. tularensis.
2  role in the oxidative stress response of F. tularensis.
3  role of OxyR has not been established in F. tularensis.
4  anthracis, Yersinia pestis, and Francisella tularensis.
5 he intramacrophage growth and survival of F. tularensis.
6 acrophage growth and survival of Francisella tularensis.
7 to macrophage inflammation in response to F. tularensis.
8 etic pathway in macrophages infected with F. tularensis.
9 the live vaccine strain (LVS) of Francisella tularensis.
10 and the antioxidant defence mechanisms of F. tularensis.
11 ired for macrophage cytokine responses to F. tularensis.
12 l for misidentification of F. novicida as F. tularensis.
13 66c as a new virulence factor in Francisella tularensis.
14 -negative coccoid rod bacterium, Francisella tularensis.
15 establishment of a fulminate infection by F. tularensis.
16 lls with the live vaccine strain (LVS) of F. tularensis.
17 d with Dichelobacter nodosus and Francisella tularensis.
18  highly divergent sequences from Francisella tularensis.
19 the live vaccine strain (LVS) of Francisella tularensis.
20 lling survival of infection with virulent F. tularensis.
21 rucial role in innate immune responses to F. tularensis.
22 al during pulmonary infection by virulent F. tularensis.
23 e lethal intracellular bacterium Francisella tularensis.
24 r zoonotic infections, including that for F. tularensis.
25 lar bears to C. burnetii, N. caninum, and F. tularensis.
26 ring intracellular infections with type A F. tularensis.
27          The assay LOD was 8.5 CFU/ml for F. tularensis, 10 CFU/ml for B. anthracis, and 4.5 CFU/ml f
28 molecular weight (VHMW)] by expressing in F. tularensis a heterologous chain-length regulator gene (w
29                                  Francisella tularensis, a Gram-negative bacterium, is the causative
30             Our objective was to identify F. tularensis-activated host signaling pathways that regula
31                                  Francisella tularensis and Anaplasma phagocytophilum alter host auto
32  the observed profiles of each of the two F. tularensis and B. anthracis strains exhibited some simil
33                                           F. tularensis and B. anthracis were grown in liquid broth f
34 ally misassembled contigs in assemblies of F.tularensis and between 31% and 100% of extensively misas
35 ) and priority pathogens such as Francisella tularensis and Burkholderia pseudomallei.
36 izoferrin is also synthesized by Francisella tularensis and Francisella novicida, but unlike R. picke
37 on of host cell death during infection by F. tularensis and highlight how shifts in the magnitude and
38 otential correlates of protection against F. tularensis and to expand and refine a comprehensive set
39 optical mapping data for loblolly pine and F.tularensis and used real optical mapping data for rice a
40 lasma gondii, Coxiella burnetii, Francisella tularensis, and Neospora caninum, estimate concentration
41 rrorism, but the pathogenic mechanisms of F. tularensis are largely unknown.
42 or this suppression of innate immunity by F. tularensis are not defined.
43 ns such as Coxiella burnetii and Francisella tularensis, as well as Coxiella-like and Francisella-lik
44             We found that viable Francisella tularensis, as well as Salmonella enterica bacteria tran
45   Here, we demonstrate a highly sensitive F. tularensis assay that incorporates sample processing and
46 ltiplex nested PCR assay for detection of F. tularensis, B. anthracis, and Y. pestis directly from pa
47 der spectrum of growth inhibition against F. tularensis , Bacillus anthracis , and Staphylococcus aur
48                                  Francisella tularensis, Bacillus anthracis, and Yersinia pestis are
49                                  Francisella tularensis bacteria acquired from infected cells were fo
50 haride antigen and 31 bacteria/mL for the F. tularensis bacteria were achieved.
51 sensor formats for the detection of whole F. tularensis bacteria were developed and their performance
52  the lipopolysaccharide (LPS) of Francisella tularensis bacteria, a Tier 1 Select Agent of bioterrori
53 In Mycobacteria tuberculosis and Francisella tularensis, biotin biosynthesis is a key fitness determi
54 llus anthracis, Yersinia pestis, Francisella tularensis, Brucella spp., Burkholderia spp., and Ricket
55 llus anthracis, Yersinia pestis, Francisella tularensis, Burkholderia mallei, Burkholderia pseudomall
56 genic bacteria: Yersinia pestis, Francisella tularensis, Burkholderia pseudomallei and Acinetobacter
57 indicate that recognition of C3-opsonized F. tularensis, but not extensive cytosolic replication, pla
58 gainst infection with attenuated Francisella tularensis, but their role in infection mediated by full
59 ed and required for virulence of Francisella tularensis by subverting the host innate immune response
60 cultative intracellular pathogen Francisella tularensis can persist in water, amoebae, and arthropods
61 e methods currently available to genotype F. tularensis cannot conclusively identify the associated s
62 findings provide compelling evidence that F. tularensis catalase restricts reactive oxygen species to
63                                  Francisella tularensis causes a lethal human disease known as tulare
64                                  Francisella tularensis causes lethal pneumonia following infection o
65                    Inhalation of Francisella tularensis causes pneumonic tularemia in humans, a sever
66 intracellular bacterial pathogen Francisella tularensis causes tularemia, a zoonosis that can be fata
67 C 25015 and on Francisella tularensis subsp. tularensis CCUG 2112, the most virulent Francisella subs
68 c immune responses and protection against F. tularensis challenge.
69 rotective effects against virulent type A F. tularensis challenge.
70 t, we evaluated Escherichia coli-Francisella tularensis chimeric variants of tmRNA and SmpB.
71  RNA-Seq we identify those regions of the F. tularensis chromosome occupied by PmrA and those genes t
72 sociates with 252 distinct regions of the F. tularensis chromosome, but exerts regulatory effects at
73 nvolved in bacterial immune evasion, like F. tularensis clpB, can serve as a model for the rational d
74  in neutrophils is necessary for limiting F. tularensis colonisation and proliferation.
75 cacy against Bacillus anthracis; Francisella tularensis; Coxiella burnetii; and Ebola, Marburg, and L
76 hepatocytic cell line compared to that of F. tularensis cultured in broth.
77 ive vaccine strain) or catalase-deficient F. tularensis (DeltakatG) show distinct profiles in their H
78                      The pathogenicity of F. tularensis depends on its ability to persist inside host
79                                           F. tularensis DNA in buffer or CFU of F. tularensis was spi
80 owever, the molecular mechanisms by which F. tularensis DsbA contributes to virulence are unknown.
81                 Here, we demonstrate that F. tularensis DsbA is a bifunctional protein that oxidizes
82 ments in F. tularensis identified over 50 F. tularensis DsbA substrates, including outer membrane pro
83 , implicate the enzyme as a potential key F. tularensis effector protein, and may help elucidate a me
84                   Infection with Francisella tularensis elicits innate and adaptive immune responses.
85 epresses inflammasome activation and that F. tularensis-encoded FTL_0325 mediates this effect.
86       The intracellular pathogen Francisella tularensis encodes a disulfide bond formation protein or
87 ted in culture by bacterial taxa Francisella tularensis (F. tularensis) subspecies novicida and Bacil
88 am-negative facultative anaerobe Francisella tularensis: F. tularensis subsp. tularensis (type A) and
89      Multiple independent acquisitions of F. tularensis from the environment over a short time period
90                                 Escape of F. tularensis from the phagosome into the cytosol of the ma
91                                  Francisella tularensis (Ft) is a highly infectious intracellular pat
92                    The bacterium Francisella tularensis (Ft) is one of the most infectious agents kno
93 such as virulent Francisella tularensis spp. tularensis (Ftt).
94 nd was applicable to multiple isolates of F. tularensis Further improvements in the accuracy and prec
95 Es) with significant homology to Francisella tularensis (gamma-proteobacteria) have been characterize
96   Several in vivo screens have identified F. tularensis genes necessary for virulence.
97 identified 95 lung infectivity-associated F. tularensis genes, including those encoding the Lon and C
98 ofile of the live vaccine strain (LVS) of F. tularensis grown in the FL83B murine hepatocytic cell li
99               A REP34 knock-out strain of F. tularensis has a reduced ability to both induce encystme
100 popolysaccharide (LPS) O antigen (OAg) of F. tularensis has been considered for use in a glycoconjuga
101 n both cases, forward primer for Francisella tularensis holarctica genomic DNA was surface immobilise
102 cribed as virulence-associated factors in F. tularensis Identification of these Lon substrates has th
103                   Trapping experiments in F. tularensis identified over 50 F. tularensis DsbA substra
104 at targeting fixed (inactivated) Francisella tularensis (iFT) organisms to FcR in mice i.n., with MAb
105 crophages (BMDMs) to inactivated Francisella tularensis (iFt)-containing immune complexes, we observe
106 ted Listeria monocytogenes expressing the F. tularensis immunoprotective antigen IglC) as the booster
107 results also demonstrate that FTL_0325 of F. tularensis impacts proIL-1beta expression as early as 2
108  this study, we demonstrate that virulent F. tularensis impairs production of inflammatory cytokines
109 st aerosol challenge with virulent type A F. tularensis in a species other than a rodent since the or
110                                  Francisella tularensis in an intracellular bacterial pathogen that c
111 er biofilm formation enhances survival of F. tularensis in aquatic or other environmental niches has
112  cartridge-based assay can rapidly detect F. tularensis in bloodstream infections directly in whole b
113 uivalents (GE) per reaction and 10 CFU/ml F. tularensis in both human and macaque blood.
114 joint infections (PJI) caused by Francisella tularensis in Europe (one in Switzerland and one in the
115 reover, p38 MAPK activity is required for F. tularensis-induced COX-2 protein synthesis, but not for
116 nase 3 (JAK3) signaling are necessary for F. tularensis-induced PGE2 production.
117                                  Francisella tularensis induces the synthesis of prostaglandin E(2) (
118 he mechanisms that recruit neutrophils to F. tularensis-infected lungs, opsonization and phagocytosis
119 sly demonstrated that PGE(2) synthesis by F. tularensis-infected macrophages requires cytosolic phosp
120                               However, in F. tularensis-infected macrophages we observed a temporal d
121 tion of AA to be converted into PGE(2) by F. tularensis-infected macrophages.
122 or memory (EM) CD4(+) T cells elicited by F. tularensis infection (postimmunization) is increased in
123 Gram-negative bacterial pathogen Francisella tularensis Infection of macrophages and their subsequent
124  elucidate a mechanistic understanding of F. tularensis infection of phagocytic cells.
125 rophil niche in CD200R(-/-) mice restores F. tularensis infection to levels seen in wild-type mice.
126     We study the pathogenesis of Francisella tularensis infection with an experimental mouse model, a
127 type mice highly sensitive to respiratory F. tularensis infection, and depletion beginning at 3 days
128 literature exists on the host response to F. tularensis infection, the vast majority of work has been
129 with the extent of necrotic damage during F. tularensis infection.
130 s interleukin 12 (IL-12) protects against F. tularensis infection; this protection was lost in MIIG m
131 n of antibodies from patients with type B F. tularensis infections and that these can be used for the
132                       We also report that F. tularensis inhibits ROS-dependent autophagy to promote i
133                                  Francisella tularensis is a category A biodefence agent that causes
134                                  Francisella tularensis is a facultative bacterial pathogen that repl
135                                  Francisella tularensis is a facultative intracellular bacterial path
136                                  Francisella tularensis is a facultative intracellular bacterium that
137                                  Francisella tularensis is a facultative intracellular bacterium that
138                                  Francisella tularensis is a facultative intracellular, Gram-negative
139                                  Francisella tularensis is a Gram-negative bacterium and the causativ
140                                  Francisella tularensis is a Gram-negative, facultative intracellular
141                                  Francisella tularensis is a highly infectious bacterium that causes
142                                  Francisella tularensis is a highly infectious intracellular bacteriu
143                                  Francisella tularensis is a highly virulent Gram-negative intracellu
144  metabolic reprogramming of host cells by F. tularensis is a key component of both inhibition of host
145                                  Francisella tularensis is a potential bioterrorism agent that is hig
146                                  Although F. tularensis is a recognized biothreat agent with broad an
147              Tularemia caused by Francisella tularensis is a zoonotic infection of the Northern Hemis
148     Because of its extreme pathogenicity, F. tularensis is classified as a category A bioweapon by th
149  The adaptive immune response to Francisella tularensis is dependent on the route of inoculation.
150      Extreme infectivity and virulence of F. tularensis is due to its ability to evade immune detecti
151 f intraocular inflammation in areas where F. tularensis is endemic.
152 e in infection mediated by fully virulent F. tularensis is not known.
153  We propose that the extreme virulence of F. tularensis is partially due to the bifunctional nature o
154                    The bacterium Francisella tularensis is recognized for its virulence, infectivity,
155  Such outbreaks are exceedingly rare, and F. tularensis is seldom recovered from clinical specimens.
156                                  Francisella tularensis is the causative agent of tularemia and a cat
157                                  Francisella tularensis is the causative agent of tularemia, a catego
158                                  Francisella tularensis is the causative agent of tularemia.
159 infectious and zoonotic pathogen Francisella tularensis is the etiologic agent of tularemia, a potent
160                                  Francisella tularensis is the etiological agent of tularemia, or rab
161 an essential virulence factor of Francisella tularensis, is a lipoprotein with two conserved domains
162  zoonose caused by the bacterium Francisella tularensis, largely refer to Parinaud's oculoglandular s
163                    Here we establish that F. tularensis limits Ca(2+) entry in macrophages, thereby l
164 ated rabbits were seropositive for IgG to F. tularensis lipopolysaccharide (LPS).
165 larensis vs Pseudomonas aeruginosa and by F. tularensis live bacteria vs the closely related bacteriu
166 ntified TolC as a virulence factor of the F. tularensis live vaccine strain (LVS) and demonstrated th
167      Using PBLs from mice vaccinated with F. tularensis Live Vaccine Strain (LVS) and related attenua
168  of OAg size in protection, we created an F. tularensis live vaccine strain (LVS) mutant with a signi
169          Intradermal inoculation with the F. tularensis live vaccine strain (LVS) results in a robust
170                      We employed Francisella tularensis live vaccine strain (LVS) to study mechanisms
171 se gene (FTL_0724) as being important for F. tularensis live vaccine strain (LVS) virulence.
172 by using unmarked deletion mutants of the F. tularensis live vaccine strain (LVS).
173 immunity against pulmonary infection with F. tularensis live vaccine strain, its production is tightl
174  mortality after pulmonary infection with F. tularensis live vaccine strain.
175 riments identified five substrates of the F. tularensis Lon protease (FTL578, FTL663, FTL1217, FTL122
176    We were particularly interested in the F. tularensis LVS (live vaccine strain) clpB (FTL_0094) mut
177 s of MAb-iFT-immunized mice subsequent to F. tularensis LVS challenge.
178  monocytes and neutrophils, infected with F. tularensis LVS ex vivo, display enhanced restriction of
179          Infection of mice in vivo with a F. tularensis LVS FTL_0724 mutant resulted in diminished mo
180  infected lungs, and control of pulmonary F. tularensis LVS growth.
181 reening a transposon insertion library of F. tularensis LVS in the presence of hydrogen peroxide, we
182                    Importantly, pulmonary F. tularensis LVS infection of MR1-deficient (MR1(-/-)) mic
183  We found that the lethality of pulmonary F. tularensis LVS infection was exacerbated under condition
184 7Ralpha(-/-) mice are more susceptible to F. tularensis LVS infection, our studies, using a virulent
185 4(+) T cells to the lungs after pulmonary F. tularensis LVS infection.
186 a critical protective role in respiratory F. tularensis LVS infection.
187  growth that can be restored to wild-type F. tularensis LVS levels by either transcomplementation, in
188    These findings further illustrate that F. tularensis LVS possesses numerous genes that influence i
189 e-derived DCs (Mo-DCs) in the lungs after F. tularensis LVS pulmonary infection.
190 tively, this study provides evidence that F. tularensis LVS represses inflammasome activation and tha
191 r of the oxidative stress response of the F. tularensis LVS.
192 thesized that the antioxidant defenses of F. tularensis maintain redox homeostasis in infected macrop
193  factors and the mechanisms through which F. tularensis mediates these suppressive effects remain rel
194 , we sought an alternative means by which F. tularensis might obtain iron.
195                        The means by which F. tularensis modulates macrophage activation are not fully
196  revealed that the immune response to the F. tularensis mutant strains was significantly different fr
197 sis Types A and B form poor biofilms, but F. tularensis mutants lacking lipopolysaccharide O-antigen,
198 oli cells yielded glycOMVs that displayed F. tularensis O-PS.
199                                      When F. tularensis OAg was purified under standard conditions, t
200  In infected macaques, the assay detected F. tularensis on days 1 to 4 postinfection in 21%, 17%, 60%
201               The data also indicate that F. tularensis pathogenesis is controlled by a highly interc
202                              The Francisella tularensis pathogenicity island (FPI) encodes many prote
203 e demonstrate that antioxidant enzymes of F. tularensis prevent the activation of redox-sensitive MAP
204                                  Francisella tularensis produces a lipopolysaccharide (LPS) that is e
205           Previously, we identified seven F. tularensis proteins that induce a rapid encystment pheno
206  wherein the immunomodulatory capacity of F. tularensis relies, at least in part, on TolC-secreted ef
207                                           F. tularensis represses inflammasome; a cytosolic multi-pro
208 ction by the live vaccine strain (LVS) of F. tularensis Resistance is characterized by reduced lethal
209  Analysis of the MglA and SspA mutants in F. tularensis reveals that interaction between PigR and the
210 assemblies of the loblolly pine, Francisella tularensis, rice and budgerigar genomes.
211 d survival upon subsequent challenge with F. tularensis Schu S4 and provided complete protection agai
212 n blood drawn from macaques infected with F. tularensis Schu S4 at daily intervals.
213 ses (LD50) of aerosolized highly virulent F. tularensis Schu S4 had a significantly higher survival r
214                                  Using an F. tularensis Schu S4 mutant library, we identified strains
215 nosis of BALB/c mice infected with either F. tularensis SCHU S4 or Y. pestis CO92.
216 C and SilC, present in the fully virulent F. tularensis Schu S4 strain for their contributions to mul
217 hallenged via aerosol with human-virulent F. tularensis SCHU S4 that had been cultivated in either Mu
218 ity island genes tested are essential for F. tularensis Schu S4 virulence and further suggest that pd
219 llowing inhalational exposure to Francisella tularensis SCHU S4, a small initial number of bacteria e
220 terminants from the select agent Francisella tularensis SCHU S4.
221 inoculated with F. novicida U112, LVS, or F. tularensis Schu S4.
222 orm of the enzyme and inhibited growth of F. tularensis SchuS4 at concentrations near that of their m
223 escribe novel inhibitors against Francisella tularensis SchuS4 FabI identified from structure-based i
224 osed to virulent (Francisella tularensis ssp tularensis SchuS4).
225 tudies, using a virulent type A strain of F. tularensis (SchuS4), indicate that IL-17Ralpha(-/-) mice
226 , with MAb-iFT immune complexes, enhances F. tularensis-specific immune responses and protection agai
227 ice with the live vaccine strain (LVS) of F. tularensis, splenic IL-10 levels increased rapidly and r
228 rial pathogens, such as virulent Francisella tularensis spp. tularensis (Ftt).
229 e from mice exposed to virulent (Francisella tularensis ssp tularensis SchuS4).
230 ed whether complement-dependent uptake of F. tularensis strain SCHU S4 affects the survival of primar
231 ulent counterparts, F. tularensis subspecies tularensis strain SCHU S4 and B. anthracis Ames.
232 strate that lipids enriched from virulent F. tularensis strain SchuS4, but not attenuated live vaccin
233 erosolized Francisella tularensis subspecies tularensis, strain SCHU S4.
234 nt clues for further understanding of the F. tularensis stress response and pathogenesis.
235 ate identification and differentiation of F. tularensis subpopulations during epidemiological investi
236 ularensis subsp. tularensis subtype A.II, F. tularensis subsp. holarctica (also referred to as type B
237 tion against challenge with two different F. tularensis subsp. holarctica (type B) live vaccine strai
238 tularensis subsp. tularensis (type A) and F. tularensis subsp. holarctica (type B).
239 de putative TPR-like proteins in Francisella tularensis subsp. holarctica FSC200.
240 ereby contributing to the survival of the F. tularensis subsp. holarctica live vaccine strain (LVS) i
241 DI-TOF) mass spectrometry on the Francisella tularensis subsp. holarctica LVS defined three protein b
242 arctica (also referred to as type B), and F. tularensis subsp. mediasiatica, as well as opportunistic
243 p. mediasiatica, as well as opportunistic F. tularensis subsp. novicida from each other and near neig
244 luding the opportunistic microbe Francisella tularensis subsp. novicida, there are considerable diffe
245 ultative anaerobe Francisella tularensis: F. tularensis subsp. tularensis (type A) and F. tularensis
246 cluster from the highly virulent Francisella tularensis subsp. tularensis (type A) strain Schu S4 in
247 a philomiragia ATCC 25015 and on Francisella tularensis subsp. tularensis CCUG 2112, the most virulen
248 ely detect and identify the hypervirulent F. tularensis subsp. tularensis subtype A.I, the virulent F
249 bsp. tularensis subtype A.I, the virulent F. tularensis subsp. tularensis subtype A.II, F. tularensis
250 s probe, providing sensitive and specific F. tularensis subspecies and subtype identification in a ra
251 in virulence observed between the various F. tularensis subspecies and subtypes.
252                                           F. tularensis subspecies holarctica was isolated from the b
253 masome during infection with the Francisella tularensis subspecies novicida (F. novicida), whereas en
254 s from their fully virulent counterparts, F. tularensis subspecies tularensis strain SCHU S4 and B. a
255 e to lethal doses of aerosolized Francisella tularensis subspecies tularensis, strain SCHU S4.
256 level with the identification of Francisella tularensis subspecies.
257 by bacterial taxa Francisella tularensis (F. tularensis) subspecies novicida and Bacillus anthracis (
258 ntify the hypervirulent F. tularensis subsp. tularensis subtype A.I, the virulent F. tularensis subsp
259 btype A.I, the virulent F. tularensis subsp. tularensis subtype A.II, F. tularensis subsp. holarctica
260  Furthermore, sequencing of the amplified F. tularensis targets provides clade confirmation and infor
261  outbreak was caused by diverse clones of F. tularensis that occurred concomitantly, were widespread,
262  SCHU S4 strain of the bacterium Francisella tularensis, that infects alveolar macrophages.
263 ts close genetic relationship to Francisella tularensis, the agent of tularemia.
264                                  Francisella tularensis, the causative agent of a fatal human disease
265 tudy, we developed a model using Francisella tularensis, the causative agent of tularemia, in which p
266                                  Francisella tularensis, the causative agent of tularemia, is most de
267                                  Francisella tularensis, the causative agent of tularemia, modulates
268                                  Francisella tularensis, the etiological agent of tularemia, is one o
269                               In Francisella tularensis, the putative DNA-binding protein PigR works
270 anism of immune evasion is the ability of F. tularensis to induce the synthesis of the small lipid me
271 ls novel pathogenic mechanisms adopted by F. tularensis to modulate macrophage innate immune function
272  delay in host cell death is required for F. tularensis to preserve its intracellular replicative nic
273 nse mechanisms, as well as the ability of F. tularensis to prolong neutrophil lifespan.
274                   Based on the ability of F. tularensis to resist high ROS/RNS levels, we have hypoth
275 er, the factors that govern adaptation of F. tularensis to the intrahepatocytic niche have not been i
276 as the highly virulent bacterium Francisella tularensis, to ensure their replication and transmission
277 d that lon and clpP are also required for F. tularensis tolerance to stressful conditions.
278 on the highly virulent bacterium Francisella tularensis tularensis.
279 e against attenuated F. tularensis versus F. tularensis type A differs.
280 FTT_0166c in the highly virulent Francisella tularensis type A strain SchuS4 are required for proper
281 of mice infected with the LVS rather than F. tularensis type A, while IL-23p19 mRNA expression was fo
282            As with phagosomal escape, the F. tularensis Type VI Secretion System (T6SS) was required
283 Francisella tularensis: F. tularensis subsp. tularensis (type A) and F. tularensis subsp. holarctica
284 ighly virulent Francisella tularensis subsp. tularensis (type A) strain Schu S4 in hypervesiculating
285                                           F. tularensis Types A and B form poor biofilms, but F. tula
286 charides may promote biofilm formation by F. tularensis Types A and B.
287 ccine-induced protection against Francisella tularensis using murine splenocytes and further demonstr
288      The Gram-negative bacterium Francisella tularensis utilizes its antioxidant armature to limit th
289 ective immune response against attenuated F. tularensis versus F. tularensis type A differs.
290                             A hallmark of F. tularensis virulence is its ability to quickly grow to h
291                                           F. tularensis virulence stems from genes encoded on the Fra
292 1548 and FTL_1709, which are required for F. tularensis virulence.
293 n to modulate both isomerase activity and F. tularensis virulence.
294      Thus, IglE is essential for Francisella tularensis virulence.
295 nal transducer and model drug by LPS from F. tularensis vs Pseudomonas aeruginosa and by F. tularensi
296     F. tularensis DNA in buffer or CFU of F. tularensis was spiked into human or macaque blood.
297 te (NZW) rabbits with aerosols containing F. tularensis We evaluated the relative humidity, aerosol e
298  Distinct VOC profiles where observed for F. tularensis when compared with B. anthracis while the obs
299       Only the OxyR homolog is present in F. tularensis, while the SoxR homologs are absent.
300 n (CDC) and include the bacteria Francisella tularensis, Yersinia pestis, Burkholderia mallei, and Br

 
Page Top